MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 1901-1910 Newer>
Managed Care
March 2005
Costly information system eventually pays off Standardized national health care information exchange and interoperability systems (HIEI), while extremely costly to implement, produce financial gains after five years. mark for My Articles 4 similar articles
BusinessWeek
April 11, 2005
Catherine Yang
Another Case Entirely Former AOL chairman Stephen M. Case's latest gig: A daring bet on hospitality and health care. mark for My Articles 46 similar articles
BusinessWeek
April 11, 2005
Catherine Arnst
Can Alcoholism Be Treated? Research shows how stubborn addictions are -- and how medications may help. Drug companies have good reason to be pay attention. mark for My Articles 160 similar articles
BusinessWeek
April 11, 2005
Arlene Weintraub
Drawing A Bead On Side Effects Drug makers are figuring out ways to make some old remedies such as Propulsid safer. mark for My Articles 640 similar articles
BusinessWeek
April 11, 2005
Arlene Weintraub
A Nano Drug's Giant Promise After seeking FDA approval for a decade, American Pharmaceutical Partners' Abraxane, which offers a less-toxic cancer treatment, has doctors and investors hopeful. mark for My Articles 78 similar articles
BusinessWeek
April 11, 2005
Amy Barrett
A Prescription For Trouble At J&J? Johnson & Johnson faces controversy over its heart failure drug Natrecor. mark for My Articles 191 similar articles
The Motley Fool
March 31, 2005
Stephen D. Simpson
The DOJ Goes Fishing for Orthopedics The government's industry-wide investigation of orthopedics is more of a buying opportunity than a real threat. mark for My Articles 72 similar articles
The Motley Fool
March 31, 2005
Stephen D. Simpson
Another "No" for Lexapro This latest FDA setback shouldn't hurt Forest Labs much, and the shares look like a bargain. mark for My Articles 186 similar articles
The Motley Fool
March 31, 2005
Stephen D. Simpson
Strike Three for Tysabri A third confirmed case of PML all but eliminates Tysabri's potential as a blockbuster drug. For Elan and Biogen investors, the news continues to sting. mark for My Articles 229 similar articles
The Motley Fool
March 30, 2005
David Nierengarten
Soothing Results, But Pain for Investors Pain Therapeutics delivers again but its stock barely budged. What gives? mark for My Articles 336 similar articles
<Older 1901-1910 Newer>    Return to current articles.